Cargando…
The role of TIM-containing molecules in airway disease and their potential as therapeutic targets
T cell immunoglobulin and mucin-domain (TIM)-containing molecules have emerged as promising therapeutic targets to correct abnormal immune function in several autoimmune and chronic inflammatory conditions. Despite the initial discovery linking TIM-containing molecules and the airway hyperreactivity...
Autores principales: | Vega-Carrascal, Isabel, Reeves, Emer P, McElvaney, Noel G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430008/ https://www.ncbi.nlm.nih.gov/pubmed/22952413 http://dx.doi.org/10.2147/JIR.S34225 |
Ejemplares similares
-
Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease
por: Caird, Robin, et al.
Publicado: (2022) -
The Involvement of Glycosaminoglycans in Airway Disease Associated with Cystic Fibrosis
por: Reeves, Emer P., et al.
Publicado: (2011) -
Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
por: McQuillan, Karen, et al.
Publicado: (2020) -
Hypertonic Saline in Treatment of Pulmonary Disease in Cystic Fibrosis
por: Reeves, Emer P., et al.
Publicado: (2012) -
Dysregulated neutrophil function in individuals with alpha-1 antitrypsin deficiency caused by modified membrane cholesterol content.
por: Jundi, Bakr, et al.
Publicado: (2015)